Bradykinin and Galectin-3 in Survived and Deceased Patients with COVID-19 Pneumonia: An Increasingly Promising Biochemical Target

Table 4

Secondary outcomes of COVID-19 patients. Statistical significance was confirmed by Chi Square Test.

Secondary outcomes	Survived []	Deceased []	Statistical significance
Duration from first symptoms to admission (days)
Duration of hospital treatment (days)
CT score
Duration of invasive mechanical ventilation (days)	0.00
Duration of noninvasive mechanical ventilation (NIV) (days)	0.00
Duration in ICU (days)	0.00